PetMed Express Analyst Ratings
PetMed Express Analyst Ratings
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $19.00 to $18.00. The current price PetMed Express (PETS) is trading at is $21.37, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2022 | -15.77% | Morgan Stanley | $19 → $18 | Maintains | Underweight |
| 07/26/2022 | -11.09% | Morgan Stanley | $20 → $19 | Maintains | Underweight |
| 05/10/2022 | -6.41% | Morgan Stanley | $21 → $20 | Maintains | Underweight |
| 01/25/2022 | -1.73% | Morgan Stanley | $25 → $21 | Maintains | Underweight |
| 01/20/2022 | 49.74% | Sidoti & Co. | → $32 | Upgrades | Neutral → Buy |
| 11/18/2021 | 16.99% | Morgan Stanley | → $25 | Initiates Coverage On | → Underweight |
| 10/01/2021 | 31.02% | Jefferies | → $28 | Initiates Coverage On | → Hold |
| 06/03/2021 | 82.5% | Sidoti & Co. | → $39 | Downgrades | Buy → Neutral |
| 03/05/2021 | — | Sidoti & Co. | Upgrades | Neutral → Buy | |
| 08/19/2020 | 91.86% | Sidoti & Co. | $37 → $41 | Upgrades | Neutral → Buy |
| 02/24/2020 | — | Sidoti & Co. | Downgrades | Buy → Neutral | |
| 10/17/2019 | -6.41% | Craig-Hallum | $15 → $20 | Maintains | Hold |
| 08/16/2019 | — | Craig-Hallum | Downgrades | Buy → Hold | |
| 07/09/2018 | — | Craig-Hallum | Downgrades | Hold → Sell | |
| 06/15/2018 | — | CL King | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 8 月 11 日 | -15.77% | 摩根士丹利 | 19 美元 → 18 美元 | 维护 | 体重不足 |
| 07/26/2022 | -11.09% | 摩根士丹利 | 20 美元 → 19 美元 | 维护 | 体重不足 |
| 05/10/2022 | -6.41% | 摩根士丹利 | 21 美元 → 20 美元 | 维护 | 体重不足 |
| 01/25/2022 | -1.73% | 摩根士丹利 | 25 美元 → 21 美元 | 维护 | 体重不足 |
| 01/20/2022 | 49.74% | Sidoti & Co. | → 32 美元 | 升级 | 中性 → 买入 |
| 11/18/2021 | 16.99% | 摩根士丹利 | → 25 美元 | 启动覆盖范围开启 | → 体重不足 |
| 10/01/2021 | 31.02% | 杰富瑞集团 | → 28 美元 | 启动覆盖范围开启 | → 按住 |
| 06/03/2021 | 82.5% | Sidoti & Co. | → 39 美元 | 降级 | 买入 → 中性 |
| 03/05/2021 | — | Sidoti & Co. | 升级 | 中性 → 买入 | |
| 2020 年 8 月 19 日 | 91.86% | Sidoti & Co. | 37 美元 → 41 美元 | 升级 | 中性 → 买入 |
| 2020 年 2 月 24 日 | — | Sidoti & Co. | 降级 | 买入 → 中性 | |
| 10/17/2019 | -6.41% | Craig-Hallum | 15 美元 → 20 美元 | 维护 | 保持 |
| 2019 年 8 月 16 日 | — | Craig-Hallum | 降级 | 买入 → 持有 | |
| 2018 年 9 月 7 日 | — | Craig-Hallum | 降级 | 持有 → 卖出 | |
| 06/15/2018 | — | CL King | 启动覆盖范围开启 | → 中立 |
PetMed Express Questions & Answers
PetMed Express 问答
The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on November 8, 2022. The analyst firm set a price target for $18.00 expecting PETS to fall to within 12 months (a possible -15.77% downside). 6 analyst firms have reported ratings in the last year.
摩根士丹利于2022年11月8日公布了PetMed Express（纳斯达克股票代码：PETS）的最新目标股价。该分析公司将目标股价定为18.00美元，预计PETS将在12个月内降至-15.77％（可能下跌15.77％）。去年有6家分析公司公布了评级。
The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.
摩根士丹利提供了PetMed Express（纳斯达克股票代码：PETS）的最新分析师评级，PetMed Express维持其减持评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on November 8, 2022 so you should expect the next rating to be made available sometime around November 8, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与PetMed Express的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。PetMed Express的最新评级是在2022年11月8日公布的，因此您应该预计下一个评级将在2023年11月8日左右公布。
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $19.00 to $18.00. The current price PetMed Express (PETS) is trading at is $21.37, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的PetMed Express（PETS）评级保持不变，目标股价为19.00美元至18.00美元。PetMed Express（PETS）目前的交易价格为21.37美元，超出了分析师的预期区间。
